Valuation: Cosmos Holdings Inc.

Market Cap 35.38M 31.05M 29.32M 26.72M 50.02M 3.39B 50.38M 351M 136M 1.73B 133M 130M 5.57B P/E 2026 *
-1.67x
P/E 2027 * 5.02x
Enterprise Value 35.38M 31.05M 29.32M 26.72M 50.02M 3.39B 50.38M 351M 136M 1.73B 133M 130M 5.57B EV / Sales 2026 *
0.44x
EV / Sales 2027 * 0.32x
Free-Float
76.24%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 60 2016-02-25
Director of Finance/CFO 43 2020-11-10
Chief Operating Officer 56 2023-01-31
Director TitleAgeSince
Director/Board Member 58 2014-01-12
Chairman 60 2016-02-25
Director/Board Member 59 2016-11-17
Change 5-day change 1-year change 3-year change Capi.($)
-5.65%-2.45% - - 38.25M
-0.31%-0.92%+17.67%+94.13% 101B
-1.08%-2.29%+47.84%+146.86% 51.55B
-0.39%+0.78%-14.33%+267.14% 20.81B
-0.25%+0.75%-10.55%-10.90% 7.93B
-1.66%-0.15%-38.22%-37.13% 6.8B
+3.71%+6.34%-0.35%+16.41% 6.52B
-0.20%-0.93%-19.00%-33.12% 5.93B
+0.30%+1.16%-2.37%+20.34% 4.95B
+1.25%+8.76%+20.44%+22.78% 4.02B
Average -0.43%+0.61%+0.13%+54.06% 23.32B
Weighted average by Cap. -0.38%-0.67%+17.01%+106.89%

Financials

2026 *2027 *
Net sales 80.8M 70.9M 66.96M 61.03M 114M 7.74B 115M 801M 310M 3.96B 303M 297M 12.72B 111M 97.23M 91.83M 83.68M 157M 10.62B 158M 1.1B 426M 5.43B 416M 407M 17.44B
Net income - -
Net Debt - -
Logo Cosmos Holdings Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
-

Quarterly revenue - Rate of surprise